|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Non-alcoholic fatty liver disease and psoriasis: So far, so near显示文摘Psoriasis is a chronic inflammatory immune-mediated skin diseases which is frequently associated to comorbidities. Non-alcoholic fatty liver disease(NAFLD) is defined as an excessive accumulation of triglycerides in hepatocytes and includes a wide spectrum of liver conditions ranging from relatively benign steatosis to non-alcoholic steatohepatitis with fatty infiltration and lobular inflammation and to cirrhosis and endstage liver disease. Actually, psoriasis is considered a systemic diseases associated to comorbidities, as metabolic syndrome and NAFLD is seen the hepatic manifestation of the metabolic syndrome. The possible link between psoriasis, obesity and metabolic syndrome, which are known risk factors for NAFLD has beenrecently documented focusing in the crucial role of the adipose tissue in the development of the inflammatory background sharing by the above entities. According to recent data, patients with psoriasis show a greater prevalence of NAFLD and metabolic syndrome than the general population. Moreover, patients with NAFLD and psoriasis are at higher risk of severe liver fibrosis than those with NAFLD and without psoriasis. The link between these pathological conditions appears to be a chronic low-grade inflammatory status. The aim of this review is to focus on the multiple aspects linking NAFLD and psoriasis, only apparently far diseases. | Giulia Ganzetti Anna Campanati Annamaria Offidani | 2015 | World Journal of Hepatology2015，7，3： | 12 |
| 2 | Psoriasis,non-alcoholic fatty liver disease,and cardiovascular disease:Three different diseases on a unique background显示文摘Psoriasis is a chronic inflammatory immune-mediated skin disease, frequently associated with systemic comorbidities. According to recent data, patients with psoriasis show a greater prevalence of metabolic syndrome, which confers a higher cardiovascular risk. The link between these pathological conditions appears to be a chronic low-grade inflammatory status. The aim of this review is to focus on the multiple epidemiological and physio-pathogenetic aspects linking non-alcoholic fatty liver disease, psoriasis, and cardiovascular disease. | Giulia Ganzetti Anna Campanati Elisa Molinelli Annamaria Offidani | 2016 | World Journal of Cardiology2016，8，2： | 4 |
| 3 | Thalidomide,dexamethasone and pegylated liposomal doxorubicin(ThaDD)for patients older than 65 years with newly diagnosed multiple myeloma显示文摘 | Corvatta L PiersanteUi MN | 2006 | Blood2006，108，： | 1 |
| 4 | Gemeitabinealone or combined with cisplatin in relapsed or refractory multiple myeloma显示文摘 | Offidani M Mele A Corvatta L | 2002 | Leuk Lymphoma2002，43，6： | 1 |
| 5 | Common and rare side -effects of low -dose thalidomide in multiple myeloma: focus on the doseminimizing peripheral neuropathy显示文摘 | Offidani M Corvatta L Marconi M | 2004 | Europ J Haematol2004，72，3： | 1 |
| 6 | Effect of biologic therapies targeting tumour necrosis factor‐α on cutaneous mesenchymal stem cells in psoriasis显示文摘 | A. Campanati M. Orciani S. Gorbi F. Regoli R. Di Primio A. Offidani | 2012 | British Journal of Dermatology2012，，： | 1 |
| 7 | In vitro activity of terbinafine against clinical isolates of dermatophytes显示文摘 | D. Arzeni F. Barchiesi P. Compagnucci A. Cellini O. Simonetti A.M. Offidani G. Scalise | 1998 | Medical Mycology1998，，4： | 1 |
| 8 | Psychopathology personality and marital relationship in patients undergoing in vitro fertilization procedures 显示文摘 | Salvatore P Gariboldi S Offidani A | 2001 | Fert steri2001，75，29： | 1 |
| 9 | Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma 显示文摘 | Offidani M Corvatta L Piersantelli MN | 2006 | Blood2006，108，7： | 1 |
| 10 | Risk assenssment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates:a historical cohort study显示文摘 | Corvatta L Malerba L | 2004 | Cancer2004，101，3： | 1 |
| 11 | Mucormycosis in hematologic patients显示文摘 | Pagano L Offidani M Fianchi L | 2004 | Haematologica2004，89，2： | 1 |
| 12 | Risk assenssment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study显示文摘 | Offidani M Corvatta L Malerba L et ul | 2004 | Cancer2004，101，3： | 1 |
| 13 | An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosedmultiple myeloma显示文摘 | Offidani M Corvatta L Caraffa P | 2014 | Onco Targets Ther2014，7，： | 1 |
| 14 | Psychological correlates in patients with different levels of hypertension 显示文摘 | Rafanelli C Offidani E Gostoli S | 2012 | Psychiatry Res2012，198，： | 1 |
| 15 | Psychopathology, personality, and marital relationship in patients undergoing in vitro fertilization procedures 显示文摘 | Salvatore P Gariboldi S Offidani A | 2001 | Fertil Steril2001，75，6： | 1 |
| 16 | Common and rare side-effects of low- dose thalidomide in multiple myeloma:focus on the dose-minimizing peripheral neuropathy显示文摘 | Offidani M Corvatta L Marconi M | 2004 | Eur J Haematol2004，72，6： | 1 |
| 17 | Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy显示文摘 | Offidani M Corvatta L Marconi M | 2004 | Eur J Haematol2004，72，6： | 1 |
| 18 | Common and rare sideeffects of low-dose thalidomide in multiple myeloma:focus on the dose-minimizing peripheral neuropathy显示文摘 | Corvatta L Marconi M | 2004 | Eur J Haematol2004，72，6： | 1 |
| 19 | Thalidomide, dexamethasone and pegylated liposomal doxorubicin (ThaDD) for newly diagnosed multiple myeloma patients over 65 years 显示文摘 | OFFIDANI M CORVATTA L PIERSANTELLI M N | 2006 | Blood2006，108，7： | 1 |
| 20 | Mucormycosis in hematologic patients显示文摘 | Pagano L Offidani M Fianchi L | 2004 | Haematologica2004，89，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员